Efficient Pharma Management Corp. (EffPha) is a full-service CRO providing drug development services, including strategic and technical consulting, non-clinical study management, biostatistics, data management, regulatory dossier preparation and submission, and clinical study management and monitoring.

We have devoted our effort to helping clients save resources and accelerate their drug development using innovative and reliable approaches and by keeping pace with the fast-changing environment for local and global regulations.

EffPha’s team of scientific and statistical experts specialize in clinical study design, and have utilized FDA’s designated Fit-For-Purpose (FFP) tool, BOIN study design, for several early phase oncology trials of our clients’ projects, which has increased flexibility and provided higher accuracy to identify the maximum tolerated dose (MTD) compared to traditional 3+3 study design for oncology drugs.

Recently, the agencies in Taiwan have commenced introducing the concept of BOIN study design and advocating its use in Phase 1 oncology studies which was demonstrated as efficient and was also recognized by the US FDA as a useful tool for drug development.

We can help advance your clinical trials through our integrated knowledge and extensive experience, and deliver customized solutions for your drug development projects.

Visit us to learn how EffPha can help support your drug development projects at https://www.effpha.com/, and you can find more details of BOIN design on our website at https://www.effpha.com/news.php?act=view&no=25.